Center for Value-based Care Research, Cleveland Clinic, Cleveland, OH, United States of America; Department of Hospital Medicine, Cleveland Clinic, Cleveland, OH, United States of America; Outcomes Research Consortium, Cleveland, OH, United States of America.
Department of Hospital Medicine, University of California, San Francisco, San Francisco, CA, United States of America.
J Clin Anesth. 2023 Nov;90:111193. doi: 10.1016/j.jclinane.2023.111193. Epub 2023 Jul 11.
To assess the incremental contribution of preoperative stress test results toward a diagnosis of obstructive coronary artery disease (CAD), prediction of mortality, or prediction of perioperative myocardial infarction in patients considering noncardiac, nonophthalmologic surgery.
DESIGN, SETTING, PARTICIPANTS: A retrospective cohort study of visits to a preoperative risk assessment and optimization clinic in a large health system between 2008 and 2018.
To assess diagnostic information of preoperative stress testing, we used the Begg and Greenes method to calculate test characteristics adjusted for referral bias, with a gold standard of angiography. To assess prognostic information, we first created multiply-imputed logistic regression models to predict 90-day mortality and perioperative myocardial infarction (MI), starting with two tools commonly used to assess perioperative cardiac risk, Revised Cardiac Risk Index (RCRI) and Myocardial Infarction or Cardiac Arrest (MICA). We then added stress test results and compared the discrimination for models with and without stress test results.
Among 136,935 visits by patients without an existing diagnosis of CAD, the decision to obtain preoperative stress testing identified around 4.0% of likely new diagnoses. Stress testing increased the likelihood of CAD (likelihood ratio: 1.31), but for over 99% of patients, stress testing should not change a decision on whether to proceed to angiography. In 117,445 visits with subsequent noncardiac surgery, stress test results failed to improve predictions of either perioperative MI or 90-day mortality. Reweighting the models and adding hemoglobin improved the prediction of both outcomes.
Cardiac stress testing before noncardiac, nonophthalmologic surgery does not improve predictions of either perioperative mortality or myocardial infarction. Very few patients considering noncardiac, nonophthalmologic surgery have a pretest probability of CAD in a range where stress testing could usefully select patients for angiography. Better use of existing patient data could improve predictions of perioperative adverse events without additional patient testing.
评估术前应激试验结果对阻塞性冠状动脉疾病(CAD)诊断、死亡率预测或非心脏、非眼科手术围手术期心肌梗死预测的增量贡献。
设计、环境、参与者:这是一项回顾性队列研究,对象为 2008 年至 2018 年期间在一个大型卫生系统的术前风险评估和优化诊所就诊的患者。
为了评估术前应激测试的诊断信息,我们使用 Begg 和 Greenes 方法计算了经过转诊偏倚调整的测试特征,以血管造影为金标准。为了评估预后信息,我们首先创建了多重插补逻辑回归模型,以预测 90 天死亡率和围手术期心肌梗死(MI),从两个常用于评估围手术期心脏风险的工具开始,即修订后的心脏风险指数(RCRI)和心肌梗死或心脏骤停(MICA)。然后,我们添加了应激测试结果,并比较了有和没有应激测试结果的模型的区分度。
在 136935 例无 CAD 现有诊断的患者就诊中,术前应激测试的决策确定了约 4.0%的可能新诊断。应激测试增加了 CAD 的可能性(似然比:1.31),但对于 99%以上的患者,应激测试不应改变是否进行血管造影的决定。在随后进行非心脏手术的 117445 例就诊中,应激测试结果未能改善围手术期 MI 或 90 天死亡率的预测。重新加权模型并添加血红蛋白可改善两种结局的预测。
非心脏、非眼科手术前的心脏应激测试并不能改善围手术期死亡率或心肌梗死的预测。考虑非心脏、非眼科手术的患者中,很少有患者的 CAD 术前概率处于应激测试可以有效选择患者进行血管造影的范围内。更好地利用现有患者数据可以在不增加患者检测的情况下改善围手术期不良事件的预测。